The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
A Highlight of Recent Advances in Aptamer Technology and Its Application
Open accessAbstract
Aptamers and SELEX (systematic evolution of ligands by exponential enrichment) technology have gained increasing attention over the past 25 years. Despite their functional similarity to protein antibodies, oligonucleotide aptamers have many unique properties that are suitable for clinical applications and industrialization. Aptamers may be superior to antibodies in fields such as biomarker discovery, in vitro and in vivo diagnosis, precisely controlled drug release, and targeted therapy. However, aptamer commercialization has not occurred as quickly as expected, and few aptamer-based products have yet successfully entered clinical and industrial use. Thus, it is important to critically review some technical barriers of aptamer and SELEX technology per se that may impede aptamer development and application. To date, how to rapidly obtain aptamers with superior bioavailability over antibodies remains the key issue. In this review, we discuss different chemical and structural modification strategies aimed to enhance aptamer bioavailability. We also discuss improvements to SELEX process steps to shorten the selection period and improve the SELEX process success rate. Applications in which aptamers are particularly suited and perform differently or superior to antibodies are briefly introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Adaptive Recognition by Nucleic Acid Aptamers
Hermann, T., & Patel, D. J. (2000) · Science · doi:10.1126/science.287.5454.820 · Cited by 1,650
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Development of DNA aptamers using Cell-SELEX
Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. B., & Tan, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.66 · Cited by 918
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Synthetic genetic polymers capable of heredity and evolution
Pinheiro, V. B., Taylor, A. I., Cozens, C., Abramov, M., Renders, M., Zhang, S., Chaput, J. C., Wengel, J., Peak-Chew, S.-Y., McLaughlin, S. H., et al. (2012) · Science · doi:10.1126/science.1217622 · Cited by 730
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., & Gold, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136683100 · Cited by 567
Replacing antibodies with aptamers in lateral flow immunoassay
Chen, A., & Yang, S. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.04.041 · Cited by 551
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Self-citationRNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S., & Hirao, I. (2013) · Nature Biotechnology · doi:10.1038/nbt.2556 · Cited by 510
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Selection of Aptamers for Molecular Recognition and Characterization of Cancer Cells
Tang, Z., Shangguan, D., Wang, K., Shi, H., Sefah, K., Mallikratchy, P., Chen, H. W., Li, Y., & Tan, W. (2007) · Analytical Chemistry · doi:10.1021/ac070189y · Cited by 479
Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells
Shangguan, D., Cao, Z., Meng, L., Mallikaratchy, P., Sefah, K., Wang, H., Li, Y., & Tan, W. (2008) · Journal of Proteome Research · doi:10.1021/pr700894d · Cited by 465
Kobayashi, H., & Choyke, P. L. (2011) · Accounts of Chemical Research · doi:10.1021/ar1000633 · Cited by 416
THE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Liang, C., Guo, B., Wu, H., Shao, N., Li, D., Liu, J., Dang, L., Wang, C., Li, H., Li, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3791 · Cited by 354
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells
Wu, Y., Sefah, K., Liu, H., Wang, R., & Tan, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909611107 · Cited by 330
Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026332 · Cited by 310
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
McNamara, J. O., Kolonias, D., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B., & Gilboa, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33365 · Cited by 310
Berezovski, M., Drabovich, A., Krylova, S. M., Musheev, M., Okhonin, V., Petrov, A., & Krylov, S. N. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042394q · Cited by 298
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Hathout, Y., Brody, E., Clemens, P. R., Cripe, L., DeLisle, R. K., Furlong, P., Gordish-Dressman, H., Hache, L., Henricson, E., Hoffman, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507719112 · Cited by 290
Aptamers as therapeutic and diagnostic reagents: problems and prospects
Osborne, S. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80102-0 · Cited by 288
SELEX with modified nucleotides
Keefe, A. D., & Cload, S. T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.028 · Cited by 283
Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics
Stoltenburg, R., Nikolaus, N., & Strehlitz, B. (2012) · Journal of Analytical Methods in Chemistry · doi:10.1155/2012/415697 · Cited by 282
Mallikaratchy, P., Tang, Z., Kwame, S., Meng, L., Shangguan, D., & Tan, W. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700026-mcp200 · Cited by 268
Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Lao, Y.-H., Phua, K. K. L., & Leong, K. W. (2015) · ACS Nano · doi:10.1021/nn507494p · Cited by 259
Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy
Wu, X., Chen, J., Wu, M., & Zhao, J. X. (2015) · Theranostics · doi:10.7150/thno.10257 · Cited by 258
Davies, D. R., Gelinas, A. D., Zhang, C., Rohloff, J. C., Carter, J. D., O’Connell, D., Waugh, S. M., Wolk, S. K., Mayfield, W. S., Burgin, A. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213933109 · Cited by 256
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Zhou, J., & Rossi, J. J. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.21 · Cited by 234
Qiu, L., Chen, T., Öçsoy, I., Yasun, E., Wu, C., Zhu, G., You, M., Han, D., Jiang, J., Yu, R., et al. (2015) · Nano Letters · doi:10.1021/nl503777s · Cited by 232
Roux-Dalvai, F., Gonzalez de Peredo, A., Simoé, C., Guerrier, L., Bouyssieé, D., Zanella, A., Citterio, A., Burlet-Schiltz, O., Boschetti, E., Righetti, P. G., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800037-mcp200 · Cited by 232
Xiang, D., Shigdar, S., Qiao, G., Wang, T., Kouzani, A. Z., Zhou, S.-F., Kong, L., Li, Y., Pu, C., & Duan, W. (2015) · Theranostics · doi:10.7150/thno.10202 · Cited by 225
Targeting cancer cells with nucleic acid aptamers
Cerchia, L., & de Franciscis, V. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.07.005 · Cited by 218
Wu, W., Zhao, S., Mao, Y., Fang, Z., Lu, X., & Zeng, L. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.12.041 · Cited by 212
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
Thiel, K. W., Hernandez, L. I., Dassie, J. P., Thiel, W. H., Liu, X., Stockdale, K. R., Rothman, A. M., Hernandez, F. J., McNamara, J. O., & Giangrande, P. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks294 · Cited by 202
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Liu, Z., Duan, J.-H., Song, Y.-M., Ma, J., Wang, F.-D., Lu, X., & Yang, X.-D. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-148 · Cited by 193
Zheng, F., Cheng, Y., Wang, J., Lu, J., Zhang, B., Zhao, Y., & Gu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201403530 · Cited by 187
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia
Mallikaratchy, P. R., Ruggiero, A., Gardner, J. R., Kuryavyi, V., Maguire, W. F., Heaney, M. L., McDevitt, M. R., Patel, D. J., & Scheinberg, D. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq996 · Cited by 186
Spiegelmers: Biostable Aptamers
Eulberg, D., & Klussmann, S. (2003) · ChemBioChem · doi:10.1002/cbic.200300663 · Cited by 181
Aptamers and Their Applications in Nanomedicine
Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 180
Self-citationMultifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Esposito, C. L., Cerchia, L., Catuogno, S., De Vita, G., Dassie, J. P., Santamaria, G., Swiderski, P., Condorelli, G., Giangrande, P. H., & de Franciscis, V. (2014) · Molecular Therapy · doi:10.1038/mt.2014.5 · Cited by 169
Aptamer based electrochemical sensors for emerging environmental pollutants
Hayat, A., & Marty, J. L. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00041 · Cited by 169
Identification of an aptamer targeting hnRNP A1 by tissue slide‐based SELEX
Li, S., Xu, H., Ding, H., Huang, Y., Cao, X., Yang, G., Li, J., Xie, Z., Meng, Y., Li, X., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2543 · Cited by 161
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG, E. W. M., & ADAMIS, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161
Wei, X., Tian, T., Jia, S., Zhu, Z., Ma, Y., Sun, J., Lin, Z., & Yang, C. J. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00532 · Cited by 158
Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
Hu, Y., Duan, J., Zhan, Q., Wang, F., Lu, X., & Yang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031970 · Cited by 149
Wu, S. Y., Yang, X., Gharpure, K. M., Hatakeyama, H., Egli, M., McGuire, M. H., Nagaraja, A. S., Miyake, T. M., Rupaimoole, R., Pecot, C. V., et al. (2014) · Nature Communications · doi:10.1038/ncomms4459 · Cited by 146
Liao, Z., Chuang, E., Lin, C.-C., Ho, Y., Lin, K., Cheng, P., Chen, K., Wei, H.-J., & Sung, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.032 · Cited by 145
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
Ni, X., Zhang, Y., Ribas, J., Chowdhury, W. H., Castanares, M. A., Zhang, Z., Laiho, M., DeWeese, T. L., & Lupold, S. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45109 · Cited by 143
Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics
Bruno, J. G. (2015) · Molecules · doi:10.3390/molecules20046866 · Cited by 133
Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery
Hoinka, J., Berezhnoy, A., Dao, P., Sauna, Z. E., Gilboa, E., & Przytycka, T. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv308 · Cited by 125
The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets
Eaton, B. E. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80103-2 · Cited by 123
AptaCluster – A Method to Cluster HT-SELEX Aptamer Pools and Lessons from Its Application
Hoinka, J., Berezhnoy, A., Sauna, Z. E., Gilboa, E., & Przytycka, T. M. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-05269-4_9 · Cited by 122
A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches
Bruno, J. G. (2013) · Pharmaceuticals · doi:10.3390/ph6030340 · Cited by 118
Ayoglu, B., Chaouch, A., Lochmüller, H., Politano, L., Bertini, E., Spitali, P., Hiller, M., Niks, E. H., Gualandi, F., Pontén, F., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303724 · Cited by 117
Quantitative selection and parallel characterization of aptamers
Cho, M., Oh, S. S., Nie, J., Stewart, R. M., Eisenstein, M. S., Chambers, J., Marth, J. D., Walker, F. M., Thomson, J. A., & Soh, H. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315866110 · Cited by 116
By-Product Formation in Repetitive PCR Amplification of DNA Libraries during SELEX
Tölle, F., Wilke, J., Wengel, J., & Mayer, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114693 · Cited by 113
Selection of an RNA domain that binds Zn2+.
Ciesiołka, J., Górski, J., & Yarus, M. (1995) · PubMed · Cited by 108
Methods for selection of aptamers to protein targets
Kulbachinskiy, A. V. (2007) · Biochemistry (Moscow) · doi:10.1134/s000629790713007x · Cited by 108
Nellore, B. P. V., Kanchanapally, R., Pramanik, A., Sinha, S. S., Chavva, S. R., Hamme, A. T., & Ray, P. C. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500503e · Cited by 107
Cohen, M. G., Purdy, D. A., Rossi, J. S., Grinfeld, L. R., Myles, S. K., Aberle, L. H., Greenbaum, A. B., Fry, E. T. A., Chan, M. Y., Tonkens, R. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927756 · Cited by 100
Novel Combinatorial Selection of Phosphorothioate Oligonucleotide Aptamers
King, D. J., Ventura, D. A., Brasier, A. R., & Gorenstein, D. G. (1998) · Biochemistry · doi:10.1021/bi981780f · Cited by 100
Zhao, N., Bagaria, H. G., Wong, M. S., & Zu, Y. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-2 · Cited by 97
Self-citationPET Imaging of Tenascin-C with a Radiolabeled Single-Stranded DNA Aptamer
Jacobson, O., Yan, X., Niu, G., Weiss, I. D., Ma, Y., Szajek, L. P., Shen, B., Kiesewetter, D. O., & Chen, X. S. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.149484 · Cited by 89
Zhou, J., Satheesan, S., Li, H., Weinberg, M. S., Morris, K. V., Burnett, J., & Rossi, J. J. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.005 · Cited by 85
Characterization and target identification of a DNA aptamer that labels pluripotent stem cells
Hou, Z., MEYER, S. R., Propson, N. E., Nie, J., Jiang, P., Stewart, R. M., & Thomson, J. A. (2015) · Cell Research · doi:10.1038/cr.2015.7 · Cited by 83
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
Santosh, B., & Yadava, P. K. (2014) · BioMed Research International · doi:10.1155/2014/540451 · Cited by 82
Pegaptanib for the treatment of age-related macular degeneration
Zhou, B., & Wang, B. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.02.010 · Cited by 81
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
Parekh, P. A., Kamble, S., Zhao, N., Zeng, Z., Portier, B. P., & Zu, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.099 · Cited by 80
Self-citationTan, L., Neoh, K. G., Kang, E. T., Choe, W. S., & Su, X. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100173 · Cited by 80
Yufa, R., Krylova, S. M., Bruce, C., Bagg, E. A. L., Schofield, C. J., & Krylov, S. N. (2014) · Analytical Chemistry · doi:10.1021/ac5044187 · Cited by 79
Hi‐Fi SELEX: A high‐fidelity digital‐PCR based therapeutic aptamer discovery platform
Ouellet, E., Foley, J. H., Conway, E. M., & Haynes, C. A. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25581 · Cited by 76
Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells
Zhang, P., Zhao, N., Zeng, Z., Feng, Y., Tung, C., Chang, C.-C., & Zu, Y. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.113 · Cited by 66
Self-citationRaston, N. H. A., & Gu, M. B. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.03.042 · Cited by 65
Methods To Identify Aptamers against Cell Surface Biomarkers
Cibiel, A., Dupont, D. M., & Ducongè, F. (2011) · Pharmaceuticals · doi:10.3390/ph4091216 · Cited by 65
Yu, D. S., Wang, D., Zhu, F., Bhagat, L., Dai, M., Kandimalla, E. R., & Agrawal, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900730r · Cited by 64
Hünniger, T., Wessels, H., Fischer, C., Paschke-Kratzin, A., & Fischer, M. J. (2014) · Analytical Chemistry · doi:10.1021/ac503261b · Cited by 61
Design, Synthesis, and Amplification of DNA Pools for In Vitro Selection
Hall, B., Micheletti, J. M., Satya, P., Ogle, K., Pollard, J. D., & Ellington, A. D. (2009) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb2402s88 · Cited by 59
Shiang, Y., Ou, C., Chen, S.-J., Ou, T.-Y., Lin, H. ‐., Huang, C., & Chang, H. (2013) · Nanoscale · doi:10.1039/c3nr33403a · Cited by 53
Duclair, S., Gautam, A. S., Ellington, A. D., & Prasad, V. R. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.1 · Cited by 52
Luo, Z., Zhou, H., Jiang, H., Ou, H., Li, X., & Zhang, L. (2015) · The Analyst · doi:10.1039/c5an00183h · Cited by 51
The anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer
Dai, F., Zhang, Y., Zhu, X., Shan, N., & Chen, Y. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.07.112 · Cited by 47
Array-based Discovery of Aptamer Pairs
Cho, M., Oh, S. S., Nie, J., Stewart, R. M., Radeke, M. J., Eisenstein, M. S., Coffey, P. J., Thomson, J. A., & Soh, H. T. (2014) · Analytical Chemistry · doi:10.1021/ac504076k · Cited by 46
Microfluidic approaches to rapid and efficient aptamer selection
Lin, H., Zhang, W., Jia, S., Guan, Z., Yang, C. J., & Zhu, Z. (2014) · Biomicrofluidics · doi:10.1063/1.4890542 · Cited by 45
Li, H., Hu, H., Zhao, Y., Chen, X., Li, W., Qiang, W., & Xu, D. (2015) · Analytical Chemistry · doi:10.1021/ac504230j · Cited by 45
A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
Zeng, Z., Tung, C., & Zu, Y. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.36 · Cited by 44
Self-citationIbach, J., Dietrich, L., Koopmans, K. R. M., Nöbel, N., Skoupi, M., & Brakmann, S. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.07.005 · Cited by 43
Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer
Taghdisi, S. M., Danesh, N. M., Emrani, A. S., Tabrizian, K., Zandkarimi, M., Ramezani, M., & Abnous, K. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.812095 · Cited by 40
In Vitro Selection Using Modified or Unnatural Nucleotides
Stovall, G. M., Bedenbaugh, R. S., Singh, S., Meyer, A. J., Hatala, P. J., Ellington, A. D., & Hall, B. (2014) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0906s56 · Cited by 38
Properties of an ‘LNA’-modified ricin RNA aptamer
Förster, C., Zydek, M., Rothkegel, M., Wu, Z., Gallin, C., Gessner, R. V., Lisdat, F., & Fürste, J. P. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.127 · Cited by 34
Kaur, J., & Tikoo, K. (2015) · Oncogene · doi:10.1038/onc.2014.447 · Cited by 33
Basile, A. S., Hutmacher, M. M., Nickens, D. J., Nielsen, J. C., Kowalski, K., Whitfield, L. R., Oishi, M., & Nakane, M. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011412961 · Cited by 26
Selection of aptamers targeting the sialic acid receptor of hemagglutinin by epitope-specific SELEX
Lao, Y., Chiang, H.-Y., Yang, D., Peck, K., & Chen, L. (2014) · Chemical Communications · doi:10.1039/c4cc03116d · Cited by 26
Aptamer-Mediated Cancer Gene Therapy
Xiang, D., Shigdar, S. L., Qiao, G. G., Zhou, S., Li, Y., Wei, M. Q., Qiao, L., Shamaileh, H. A., Zhu, Y., Zheng, C., et al. (2015) · Current Gene Therapy · doi:10.2174/1566523214666141224095105 · Cited by 23
Design, Synthesis, and Amplification of DNA Pools for In Vitro Selection
Pollard, J. D., Bell, S. D., & Ellington, A. D. (2000) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0902s00 · Cited by 23
Georges, J., Liu, X., Eschbacher, J., Nichols, J., Mooney, M. A., Joy, A. M., Spetzler, R. F., Feuerstein, B. G., Preul, M. C., Anderson, T. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123607 · Cited by 18
Selective Aptamer‐Based Control of Intraneuronal Signaling
Lennarz, S., Alich, T. C., Kelly, T., Blind, M., Beck, H., & Mayer, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201409597 · Cited by 13
Guo, W. M., Kong, K. W., Brown, C. J., Quah, S. T., Yeo, H. L., Hoon, S. S., & Seow, Y. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.70 · Cited by 11
Cited by
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
Li, L., Xu, S., Yan, H., Li, X., Yazd, H. S., Li, X., Huang, T., Cui, C., Jiang, J., & Tan, W. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202003563 · Cited by 432
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
SELEX: Critical factors and optimization strategies for successful aptamer selection
Kohlberger, M., & Gadermaier, G. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2244 · Cited by 341
Detection and beyond: challenges and advances in aptamer-based biosensors
Yoo, H., Jo, H., & Oh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00639d · Cited by 334
Metadata
- Authors
- Sun, H., & Zu, Y.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2015-06-30
- Volume
- 20
- Issue
- 7
- Pages
- 11959-11980
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W1621386139
- Cited by
- 316
- References
- 109
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.